MicroRNA-301b-3p facilitates cell proliferation and migration in colorectal cancer by targeting HOXB1

References

• Global burden of disease cancer C, Fitzmaurice C, Abate D, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol. 2019;5:1749–1768.
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249.
   PubMed Web of Science ®Google Scholar
• Cardoso R, Guo F, Heisser T, et al. Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study. Lancet Oncol. 2021;22(7):1002–1013.
   PubMed Web of Science ®Google Scholar
• Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019;16(12):713–732.
   PubMed Web of Science ®Google Scholar
• Connell LC, Mota JM, Braghiroli MI, et al. The rising incidence of younger patients with colorectal cancer: questions about screening, biology, and treatment. Curr Treat Options Oncol. 2017;18(4):23.
   PubMed Web of Science ®Google Scholar
• Biller LH, Schrag D. Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA. 2021;325(7):669–685.
   PubMed Web of Science ®Google Scholar
• Keller DS, Berho M, Perez RO, et al. The multidisciplinary management of rectal cancer. Nat Rev Gastroenterol Hepatol. 2020;17(7):414–429.
   PubMed Web of Science ®Google Scholar
• Jung G, Hernandez-Illan E, Moreira L, et al. Epigenetics of colorectal cancer: biomarker and therapeutic potential. Nat Rev Gastroenterol Hepatol. 2020;17(2):111–130.
   PubMed Web of Science ®Google Scholar
• Abbema DV, Vissers P, Vos-Geelen J, et al. Trends in overall survival and treatment patterns in two large population-based cohorts of patients with breast and colorectal cancer. Cancers (Basel). 2019;11.
   PubMedGoogle Scholar
• Elferink MA, van Steenbergen LN, Krijnen P, et al. Marked improvements in survival of patients with rectal cancer in the Netherlands following changes in therapy, 1989-2006. Eur J Cancer. 2010;46(8):1421–1429.
   PubMed Web of Science ®Google Scholar
• Rasool M, Malik A, Waquar S, et al. Assessment of clinical variables as predictive markers in the development and progression of colorectal cancer. Bioengineered. 2021;12(1):2288–2298.
   PubMed Web of Science ®Google Scholar
• Xie L, Pan Z. Circular RNA circ_0000467 regulates colorectal cancer development via mir-382-5p/en2 axis. Bioengineered. 2021;12(1):886–897.
   PubMed Web of Science ®Google Scholar
• Hua Q, Xu W, Shen X, et al. Dynamic changes of plasma extracellular vesicle long RNAs during perioperative period of colorectal cancer. Bioengineered. 2021;12(1):3699–3710.
   PubMed Web of Science ®Google Scholar
• Slattery ML, Mullany LE, Sakoda LC, et al. Dysregulated genes and miRNAs in the apoptosis pathway in colorectal cancer patients. Apoptosis. 2018;23(3–4):237–250.
   PubMed Web of Science ®Google Scholar
• Yang F, Wang H, Yan B, et al. Decreased level of mir-1301 promotes colorectal cancer progression via activation of stat3 pathway. Biol Chem. 2021;402(7):805–813.
   Web of Science ®Google Scholar
• Sun L, Fang Y, Wang X, et al. Mir-302a inhibits metastasis and cetuximab resistance in colorectal cancer by targeting NFIB and CD44. Theranostics. 2019;9(26):8409–8425.
   PubMed Web of Science ®Google Scholar
• Liu D, Chen C, Cui M, et al. Mir-140-3p inhibits colorectal cancer progression and its liver metastasis by targeting bcl9 and bcl2. Cancer Med. 2021;10(10):3358–3372.
   PubMed Web of Science ®Google Scholar
• Fan Y, Li Y, Zhu Y, et al. Mir-301b-3p regulates breast cancer cell proliferation, migration, and invasion by targeting nr3c2. J Oncol. 2021;2021:8810517.
   PubMed Web of Science ®Google Scholar
• Liu H, Ma X, Niu N, et al. Mir-301b-3p promotes lung adenocarcinoma cell proliferation, migration and invasion by targeting dlc1. Technol Cancer Res Treat. 2021;20:1533033821990036.
   Web of Science ®Google Scholar
• Fan H, Jin X, Liao C, et al. microRNA-301b-3p accelerates the growth of gastric cancer cells by targeting zinc finger and btb domain containing 4. Pathol Res Pract. 2019;215(11):152667.
   PubMed Web of Science ®Google Scholar
• Guo Y, Yao B, Zhu Q, et al. Micro RNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4. J Cell Mol Med. 2019;23(8):5037–5047.
   PubMed Web of Science ®Google Scholar
• Zhou JL, Deng S, Fang HS, et al. Hsa-let-7g promotes osteosarcoma by reducing hoxb1 to activate nf-kb pathway. Biomed Pharmacother. 2019;109:2335–2341.
   PubMed Web of Science ®Google Scholar
• Cui F, Zhou Q, Xiao K, et al. The microRNA hsa-let-7g promotes proliferation and inhibits apoptosis in lung cancer by targeting hoxb1. Yonsei Med J. 2020;61(3):210–217.
   PubMed Web of Science ®Google Scholar
• Han L, Liu D, Li Z, et al. Hoxb1 is a tumor suppressor gene regulated by mir-3175 in glioma. PLoS One. 2015;10(11):e0142387.
   PubMed Web of Science ®Google Scholar
• Varnholt H, Drebber U, Schulze F, et al. microRNA gene expression profile of hepatitis c virus-associated hepatocellular carcinoma. Hepatology. 2008;47(4):1223–1232.
   PubMed Web of Science ®Google Scholar
• Luo Z, Rong Z, Zhang J, et al. Circular RNA circccdc9 acts as a mir-6792-3p sponge to suppress the progression of gastric cancer through regulating cav1 expression. Mol Cancer. 2020;19(1):86.
   PubMed Web of Science ®Google Scholar
• Petrini M, Felicetti F, Bottero L, et al. Hoxb1 restored expression promotes apoptosis and differentiation in the hl60 leukemic cell line. Cancer Cell Int. 2013;13(1):101.
   PubMedGoogle Scholar